ARCHIVES

FDA Approves Velcade For Treatment Of Refractory Multiple Myeloma

This article is from The Cancer Letter archive.

Vol. 26 No. 5 | May 30, 2003

Download PDF Visit The Full Archive

Related Articles

Combined analysis moves Herceptin to adjuvant setting in breast cancer.

May 27, 2005

ODAC Endorses Tamoxifen Trial, With Modification to Ensure Enrollment of Women At Higher Risk

August 2, 1991

Health Care Reform: Fundamental changes Ahead For Cancer Research And Care

October 8, 1993

In Brief: Paul Van Nevel, Director Of NCI Communications, To Retire At Year’s End

November 26, 1999

National Cancer Act Of 1971 Commemorated In Symposium Marking Progress, Future Goals

December 13, 1991

Ethics Commission To Take Up Again Compensation Issue

September 11, 1981